Sorenson John Bradley's Form 4 filing
Boston Scientific CorpBSX · filed May 6, 2025
- Accession no.
- 0001225208-25-004792
- Filed
- May 6, 2025
- Trade date
- May 2-5, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $478.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sorenson John BradleyCIK 0001629277 | Officer (EVP, Global Operations) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 2, 2025 | Common Stock | MOption exerciseAcquired | +4,204 | $0.00F1 | $0 | 25,195 | Direct | |
| May 2, 2025 | Common Stock | FTax withholdingDisposed | −1,918 | $104.93 | −$201,255.74 | 23,277 | Direct | |
| May 5, 2025 | Common Stock | SSaleDisposed | −4,572 | $104.54 | −$477,956.88 | 18,705 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 2, 2025 | Common Stock | MOption exerciseDisposed | −4,204 | $0.00 | $0 | 4,204 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Referenced by the price of 1 transaction in Table I.